Diabetes Technology

Latest News

Benefits of Continuous Glucose Monitoring Systems in the Hospital Setting

By

Amit Akirov, MD

Continuous glucose monitoring is a safe and useful method to measure blood glucose levels in the hospital, especially during the COVID-19 pandemic.

Continuous Glucose Monitoring Aids Glycemic Control in Young Adults With Diabetes

Continuous glucose monitoring improves glycemic control in adolescents and young adults with T1D and is beneficial for hypoglycemia in older adults with T1D.

FreeStyle Libre 2 Cleared for Use in Adults and Pediatric Patients With Diabetes

By

Diana Ernst, RPh

The FDA has approved the FreeStyle® Libre 2 integrated continuous glucose monitoring system (Abbott) for adults and children ≥4 years of age with diabetes.

Use of CGM at Diabetes Camps May Reduce Hypoglycemia in Campers

By

Rachael Beairsto

Use of continuous glucose monitoring significantly decreases rates of hypoglycemia among children and adolescents who attend diabetes camps.

Using Smartphone Apps for Glycemic Control in Diabetes: What Improvements Are Still Needed?

By

Madeline Morr

Researchers analyzed diabetes mobile applications to evaluate patient self-management capabilities and the compliance of these apps with diabetes care guidelines.

Implementing CGM for Hospitalized Patients With COVID-19 and Diabetes: Insights From One Medical Center

By

Rachael Beairsto

In-hospital use of continuous glucose monitoring may offer improvements in glycemic control and reduced exposure to COVID-19 for healthcare professionals.

Recommendations for Effective Implementation of Telehealth for Diabetes Care

By

Amit Akirov, MD

Experts provide recommendations for effective implementation of telehealth for diabetes care, with a focus on patient-to-clinic video encounters.

Telemedicine for Diabetes Management During the COVID-19 Pandemic and Beyond

By

Tori Rodriguez, MA, LPC, AHC

Changes to restrictions for telemedicine may have important implications for the management of adult and pediatric diabetes during the COVID-19 pandemic.

Glycemic Control Good for Regular Human Insulin With V-Go Device

For patients with T2D, glycemic control is similar with use of regular human insulin and rapid-acting insulin when delivered with a wearable insulin delivery device, V-Go.

Real-World Data Analyzed for Use of Insulin Pump System in T1D

Real-world data support the benefit of using the Medtronic MiniMed 670G insulin pump system for glycemic control in type 1 diabetes.

Importance of Temporal Glucose Profiles During Pregnancy in Type 1 Diabetes

By

Amit Akirov, MD

Applying functional data analysis to continuous glucose monitoring data can assist in identifying differences in maternal glucose control during pregnancy, which might go unnoticed using standard metrics.